Insights

Media

Early Evidence Generation: A Strategic Roadmap to Successful Market Access
Early Evidence Generation: A Strategic Roadmap to Successful Market Access
Evidence development
Health technology assessment
13/9/2024
The Power of Early Evidence in Market Access
The Power of Early Evidence in Market Access
Evidence development
Health technology assessment
11/6/2024
Demonstrating value: Real-World Evidence (RWE) in IRA’s Medicare Drug Price Negotiation
Demonstrating value: Real-World Evidence (RWE) in IRA’s Medicare Drug Price Negotiation
Evidence development
Health technology assessment
2/2/2024
Getting real: real-world evidence in healthcare
Getting real: real-world evidence in healthcare
Medical writing
Evidence development
28/6/2023
My summer internship at Symmetron
My summer internship at Symmetron
Health economic modelling
3/3/2023
A cloud computing solution for improving the run-time of individual patient simulation models
A cloud computing solution for improving the run-time of individual patient simulation models
Health technology assessment
Statistical analysis
Health economic modelling
16/12/2022
Unmet medical need and market access: enabler or barrier to innovation?
Unmet medical need and market access: enabler or barrier to innovation?
Health technology assessment
17/8/2022
What is qualitative evidence synthesis?
What is qualitative evidence synthesis?
Evidence development
Statistical analysis
Health technology assessment
25/5/2022
Market access: budget impact analysis
Market access: budget impact analysis
Health economic modelling
Health technology assessment
Statistical analysis
24/11/2022
When is a simple model enough? How to handle structural uncertainty in cost-effectiveness models.
When is a simple model enough? How to handle structural uncertainty in cost-effectiveness models.
Health economic modelling
10/6/2021
Health economic modelling: a guide for pharmaceutical and medical device companies
Health economic modelling: a guide for pharmaceutical and medical device companies
Health economic modelling
21/8/2021
Evidence generation and communication in drug development
Evidence generation and communication in drug development
Evidence development
Health technology assessment
Medical writing
13/8/2021
Market access for immuno-oncology (I-O) therapies in the UK
Market access for immuno-oncology (I-O) therapies in the UK
Health economic modelling
Health technology assessment
6/7/2021
Evidence synthesis for healthcare decision-making
Evidence synthesis for healthcare decision-making
Evidence development
Health technology assessment
Medical writing
13/8/2021
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Stay in touch

Subscribe to Symmetron and stay up to date with recent news and announcements.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.